TY - THES A1 - Friedrich, Maria T1 - Neue metallreiche [n]Metalloarenophane: Synthese, Struktur und katalytische Aktivität T1 - New metal-enriched [n]Metalloarenophanes: Synthesis, Structure and Catalytic Activity N2 - Ausgehend von den dilithiierten Verbindungen [Cr(C6H5Li)2]·(tmeda), [Cr(C5H4Li)(C7H6Li)]·(tmeda) und [Mn(C5H4Li)(C6H5Li)]·(tmeda) konnten durch Umsetzung mit Elementdihalogeniden der Gruppe 4 neue [1]Metalloarenophane synthetisiert werden. Aufgrund des großen Kovalenzradius von Zirkon weisen diese Spezies erwartungsgemäß nur sehr geringe Molekülspannungen auf, weshalb deren intensive Färbung nicht allein auf eine mit der Verbrückung einhergehende Verkleinerung des HOMO-LUMO-Abstandes zurückgeführt werden konnte. Die UV-Vis-spektroskopischen Untersuchungen zeigten ein nicht einheitliches Verhalten, so dass deren Hintergrund mittels zeitabhängiger DFT-Rechnungen (B3LYP/BP86) untersucht wurden. Den Rechnungen zufolge muss bei der niederenergetischsten Anregung dieser [1]Metalloarenophane ein starker elektronischer Einfluss der ansa-Brücke mit berücksichtigt werden. Die Übergänge finden demnach aus dem metallzentrierten HOMO in das LUMO statt, welches hauptsächlich an der Zr-Brücke lokalisiert ist. Des Weiteren ist es gelungen, heteroleptische 1,1 ́-Bis(phosphanyl)trochrocenderivate darzustellen. Neben NMR-spektroskopischen Experimenten belegen auch Kristallstrukturanalysen die Gegenwart nahezu ungespannter Systeme. Die Reaktivität dieser 1,1 ́-Bis(phosphane) in Hinblick auf deren Verwendung als Chelatliganden wurde durch deren Umsetzung mit Metallcarbonylen der Gruppe 6 sowie mit geeigneten Palladium- und Platinkomplexen untersucht. Auf diese Weise konnten bimetallische [3]Trochrocenophane erhalten werden. Durch Umsetzung mit MeLi bzw. M-C≡C-Ph (M = Li, Na) ist es in weiterführenden Experimenten gelungen, die disubstituierten Spezies darzustellen, welche eine deutlich erhöhte Löslichkeit als die entsprechenden MCl2-verbrückten Ausgangsverbindungen zeigten und konnten isoliert und in Lösung vollständig durch NMR-Spektroskopie charakterisiert werden. Die Ergebnisse dieser Studien stehen erwartungsgemäß im Einklang mit der Gegenwart ungespannter Systeme, was weiterhin durch Röntgenstrukturanalysen belegt werden konnte. Die Eignung der PdCl2-verbrückten 1,1´-Bis(phosphanyl)trochrocene als Katalysator für die Heck-Reaktion wurde weiterhin untersucht. Katalysestudien zur Umsetzung von Brombenzol mit Styrol zu trans- und cis-Stilben belegen eindeutig die katalytische Aktivität dieser Spezies. N2 - Based on the reaction of the dilithiated species [Cr(C6H5Li)2]·(tmeda), [Cr(C5H4Li)(C7H6Li)]·(tmeda) and [Mn(C5H4Li)(C6H5Li)]·(tmeda) with group 4 metal dichlorides new [1]metalloarenophanes were obtained. Due to the large covalent radius of the zirconium atom all species exhibit, as expected, little molecular ring strain. Therefore their intense colouration can not arise merely by the reduction of the HOMO-LUMO gap due to tilting. UV-Vis spectroscopy show an irregular trend, for which reason time-dependent DFT calculations (B3LYP/BP86) were conducted. According to these, the ansa-bridge executes a strong electronic influence on the lowest-energy transition in these [1]metalloarenophanes. These transitions arise from metal-centered orbitals (HOMO) to acceptor orbitals, predominately located at the zirconium bridge (LUMO). Furthermore, heteroleptic 1,1 ́-bis(phosphanyl)trochrocene derivatives could be obtained. In addition to solution NMR spectroscopic characterisation, the nonstrained character was further validated by X-ray diffraction analysis. The suitability of these 1,1 ́-bis(phosphanyles) to act as chelating ligands was subsequently evaluated by reactivity studies toward group 6 metalcarbonyls and adequate palladium- and platinum complexes. By this way the bimetallic [3]trochrocenophanes could be obtained. By further reaction with MeLi or M-C≡C-Ph (M = Li, Na) the disubstituted species could be synthesised. In contrast to their MCl2-precursors they show an increased solubility were isolated and fully characterised by solution NMR spectroscopy. Results of these studies suggest, as expected, the non-strained character of these systems, which is further validated by X-ray diffraction analysis. The applicability of the PdCl2-bridged 1,1´-bis(phosphanyl)trochrocenes to act as catalysts in the Heck reaction was investigated. Catalytic studies on the reaction of bromobenzene with styrene to trans- and cis-stilbene demonstrate the activity of these species. KW - Metallocene KW - Sandwich-Verbindungen KW - Heck-Reaktion KW - Metalloarenophane KW - Bis(phosphanyle) KW - Metalloarenophanes KW - Bis(phosphanyles) Y1 - 2011 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-66893 ER - TY - JOUR A1 - Wiegering, Armin A1 - Pfann, Christina A1 - Uthe, Friedrich Wilhelm A1 - Otto, Christoph A1 - Rycak, Lukas A1 - Mäder, Uwe A1 - Gasser, Martin A1 - Waaga-Gasser, Anna-Maria A1 - Eilers, Martin A1 - Germer, Christoph-Thomas T1 - CIP2A Influences Survival in Colon Cancer and Is Critical for Maintaining Myc Expression JF - PLoS ONE N2 - The cancerous inhibitor of protein phosphatase 2A (CIP2A) is an oncogenic factor that stabilises the c-Myc protein. CIP2A is overexpressed in several tumours, and expression levels are an independent marker for long-term outcome. To determine whether CIP2A expression is elevated in colon cancer and whether it might serve as a prognostic marker for survival, we analysed CIP2A mRNA expression by real-time PCR in 104 colon cancer samples. CIP2A mRNA was overexpressed in colon cancer samples and CIP2A expression levels correlated significantly with tumour stage. We found that CIP2A serves as an independent prognostic marker for disease-free and overall survival. Further, we investigated CIP2A-dependent effects on levels of c-Myc, Akt and on cell proliferation in three colon cancer cell lines by silencing CIP2A using small interfering (si) and short hairpin (sh) RNAs. Depletion of CIP2A substantially inhibited growth of colon cell lines and reduced c-Myc levels without affecting expression or function of the upstream regulatory kinase, Akt. Expression of CIP2A was found to be dependent on MAPK activity, linking elevated c-Myc expression to deregulated signal transduction in colon cancer. KW - caco-2 cells KW - carcinomas KW - colon KW - colorectal cancer KW - MAPK signaling cascades KW - metastasis KW - protein expression KW - small interferring RNA Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-97252 ER - TY - JOUR A1 - Benoit, Joshua B. A1 - Adelman, Zach N. A1 - Reinhardt, Klaus A1 - Dolan, Amanda A1 - Poelchau, Monica A1 - Jennings, Emily C. A1 - Szuter, Elise M. A1 - Hagan, Richard W. A1 - Gujar, Hemant A1 - Shukla, Jayendra Nath A1 - Zhu, Fang A1 - Mohan, M. A1 - Nelson, David R. A1 - Rosendale, Andrew J. A1 - Derst, Christian A1 - Resnik, Valentina A1 - Wernig, Sebastian A1 - Menegazzi, Pamela A1 - Wegener, Christian A1 - Peschel, Nicolai A1 - Hendershot, Jacob M. A1 - Blenau, Wolfgang A1 - Predel, Reinhard A1 - Johnston, Paul R. A1 - Ioannidis, Panagiotis A1 - Waterhouse, Robert M. A1 - Nauen, Ralf A1 - Schorn, Corinna A1 - Ott, Mark-Christoph A1 - Maiwald, Frank A1 - Johnston, J. Spencer A1 - Gondhalekar, Ameya D. A1 - Scharf, Michael E. A1 - Raje, Kapil R. A1 - Hottel, Benjamin A. A1 - Armisén, David A1 - Crumière, Antonin Jean Johan A1 - Refki, Peter Nagui A1 - Santos, Maria Emilia A1 - Sghaier, Essia A1 - Viala, Sèverine A1 - Khila, Abderrahman A1 - Ahn, Seung-Joon A1 - Childers, Christopher A1 - Lee, Chien-Yueh A1 - Lin, Han A1 - Hughes, Daniel S.T. A1 - Duncan, Elizabeth J. A1 - Murali, Shwetha C. A1 - Qu, Jiaxin A1 - Dugan, Shannon A1 - Lee, Sandra L. A1 - Chao, Hsu A1 - Dinh, Huyen A1 - Han, Yi A1 - Doddapaneni, Harshavardhan A1 - Worley, Kim C. A1 - Muzny, Donna M. A1 - Wheeler, David A1 - Panfilio, Kristen A. A1 - Jentzsch, Iris M. Vargas A1 - Jentzsch, IMV A1 - Vargo, Edward L. A1 - Booth, Warren A1 - Friedrich, Markus A1 - Weirauch, Matthew T. A1 - Anderson, Michelle A.E. A1 - Jones, Jeffery W. A1 - Mittapalli, Omprakash A1 - Zhao, Chaoyang A1 - Zhou, Jing-Jiang A1 - Evans, Jay D. A1 - Attardo, Geoffrey M. A1 - Robertson, Hugh M. A1 - Zdobnov, Evgeny M. A1 - Ribeiro, Jose M.C. A1 - Gibbs, Richard A. A1 - Werren, John H. A1 - Palli, Subba R. A1 - Schal, Coby A1 - Richards, Stephen T1 - Unique features of a global human ectoparasite identified through sequencing of the bed bug genome JF - Nature Communications N2 - The bed bug, Cimex lectularius, has re-established itself as a ubiquitous human ectoparasite throughout much of the world during the past two decades. This global resurgence is likely linked to increased international travel and commerce in addition to widespread insecticide resistance. Analyses of the C. lectularius sequenced genome (650 Mb) and 14,220 predicted protein-coding genes provide a comprehensive representation of genes that are linked to traumatic insemination, a reduced chemosensory repertoire of genes related to obligate hematophagy, host–symbiont interactions, and several mechanisms of insecticide resistance. In addition, we document the presence of multiple putative lateral gene transfer events. Genome sequencing and annotation establish a solid foundation for future research on mechanisms of insecticide resistance, human–bed bug and symbiont–bed bug associations, and unique features of bed bug biology that contribute to the unprecedented success of C. lectularius as a human ectoparasite. KW - human ectoparasite KW - bed bug KW - Cimex lectularius KW - genome Y1 - 2016 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-166221 VL - 7 IS - 10165 ER - TY - JOUR A1 - Schmitt, Elke A1 - Meybohm, Patrick A1 - Neef, Vanessa A1 - Baumgarten, Peter A1 - Bayer, Alexandra A1 - Choorapoikayil, Suma A1 - Friederich, Patrick A1 - Friedrich, Jens A1 - Geisen, Christof A1 - Güresir, Erdem A1 - Grünewald, Matthias A1 - Gutjahr, Martin A1 - Helmer, Philipp A1 - Herrmann, Eva A1 - Müller, Markus A1 - Narita, Diana A1 - Raadts, Ansgar A1 - Schwendner, Klaus A1 - Seifried, Erhard A1 - Stark, Patrick A1 - Steinbicker, Andrea U. A1 - Thoma, Josef A1 - Velten, Markus A1 - Weigt, Henry A1 - Wiesenack, Christoph A1 - Wittmann, Maria A1 - Zacharowski, Kai A1 - Piekarski, Florian T1 - Preoperative anaemia and red blood cell transfusion in patients with aneurysmal subarachnoid and intracerebral haemorrhage - a multicentre subanalysis of the German PBM Network Registry JF - Acta Neurochirurgica N2 - Purpose Anaemia is common in patients presenting with aneurysmal subarachnoid (aSAH) and intracerebral haemorrhage (ICH). In surgical patients, anaemia was identified as an idenpendent risk factor for postoperative mortality, prolonged hospital length of stay (LOS) and increased risk of red blood cell (RBC) transfusion. This multicentre cohort observation study describes the incidence and effects of preoperative anaemia in this critical patient collective for a 10-year period. Methods This multicentre observational study included adult in-hospital surgical patients diagnosed with aSAH or ICH of 21 German hospitals (discharged from 1 January 2010 to 30 September 2020). Descriptive, univariate and multivariate analyses were performed to investigate the incidence and association of preoperative anaemia with RBC transfusion, in-hospital mortality and postoperative complications in patients with aSAH and ICH. Results A total of n = 9081 patients were analysed (aSAH n = 5008; ICH n = 4073). Preoperative anaemia was present at 28.3% in aSAH and 40.9% in ICH. RBC transfusion rates were 29.9% in aSAH and 29.3% in ICH. Multivariate analysis revealed that preoperative anaemia is associated with a higher risk for RBC transfusion (OR = 3.25 in aSAH, OR = 4.16 in ICH, p < 0.001), for in-hospital mortality (OR = 1.48 in aSAH, OR = 1.53 in ICH, p < 0.001) and for several postoperative complications. Conclusions Preoperative anaemia is associated with increased RBC transfusion rates, in-hospital mortality and postoperative complications in patients with aSAH and ICH. KW - aneurysmal subarachnoid haemorrhage KW - intracerebral haemorrhage KW - anaemia KW - red blood cell transfusion KW - patient blood management Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-346754 VL - 164 ER -